Investor profile
Gilde Healthcare has backed 15 European tech companies across 19 funding rounds between 2005 and 2025, joining rounds totalling €810M. Most active in Healthtech and Hardware. Data as of 7 Aug 2026.
Also recorded as: Gilde Healthcare Partners
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Fire1 | Ireland | 3 | €179M |
| SpliceBio | Spain | 2 | €168M |
| Noema Pharma | Switzerland | 2 | €134M |
| ProVerum | Ireland | 1 | €68M |
| WiThings | France |
| 1 |
| €51M |
| Breath Therapeutics | Germany | 1 | €44M |
| Sanifit | Spain | 1 | €37M |
| STAT-Diagnostica | Spain | 1 | €25M |
| Symphogen | Denmark | 1 | €21M |
| Calypso Biotech | Netherlands | 1 | €20M |
| Nyxoah | Belgium | 1 | €18M |
| NightBalance | Netherlands | 1 | €13M |
| AM-Pharma | Netherlands | 1 | €12M |
| Draupnir Bio | Denmark | 1 | €12M |
| Qinec | UK | 1 | €8.3M |
| €68M |
| 2025-08 |
| WiThings | Series B | €51M | 2020-07 |
| SpliceBio | Series A | €50M | 2022-02 |
| Breath Therapeutics | Series A | €44M | 2017-03 |
| Fire1 | Series C | €40M | 2018-01 |
| Sanifit | Series C | €37M | 2015-09 |
| Noema Pharma | Series B | €29M | 2024-12 |
